Carol Witczak

Joslin Diabetes Center

$3,063,086

Attributed

$3,063,086

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $356.6K · FY2006–23

$500K$375K$250K$125K$0

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

Funding mix

By agency

NIH$3,063,086 · 5

By mechanism

R01$1,676,573 · 1

R00$734,551 · 1

R21$383,570 · 1

K99$178,120 · 1

F32$90,272 · 1

Top collaborators

No co-investigators on record.

Most similar at Joslin Diabetes Center

Same institution · by research overlap

Others in their field

Top investigators on “In Vivo”

David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
Dennis R. Burton · Scripps Research Institute$212,708,174
Mark S Klempner · Tufts Medical Center$128,021,180
Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200

Research focus

In VivoMuscleSignaling ProteinCa(2+)-Calmodulin Dependent Protein KinaseMolecularSignal TransductionGene TransferProtein BiosynthesisSignal PathwayRegulationMetabolicPhosphotransferasesMuscle FormGlucose UptakeGrowthDiabetes MellitusPlayCalcium/Calmodulin-Dependent Protein KinasePharmacologic SubstanceMuscle ProteinsPathway InteractionsProtein-Serine-Threonine KinasesAttenuatedMalignant Neoplasms